Neovascularx, Inc.

Manteca, CA Part of AMD Therapeutics LLC

UEI
SMWUHJ7LPHY3
CAGE
9ZF60
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
455 Cherry Ln APT L, Manteca, CA 95337, USA
Website
neovascular-stop.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Neovascularx, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Topical ophthalmic treatment for neovascular age-related macular degeneration (namd) - project summary the long-term… Grant · R43EY038159 National Eye Institute $305,321

Quick answers

What is Neovascularx, Inc.'s UEI?

Neovascularx, Inc.'s Unique Entity ID (UEI) in SAM.gov is SMWUHJ7LPHY3.

What is Neovascularx, Inc.'s CAGE code?

Neovascularx, Inc.'s CAGE code is 9ZF60.

What is Neovascularx, Inc.'s primary NAICS code?

Neovascularx, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Neovascularx, Inc. located?

Neovascularx, Inc.'s physical address in SAM.gov is 455 Cherry Ln APT L, Manteca, CA 95337, USA.

Is Neovascularx, Inc. registered in SAM.gov?

Yes. Neovascularx, Inc.'s SAM.gov registration is active through June 26, 2027.

Who is Neovascularx, Inc.'s parent company?

Neovascularx, Inc. is part of AMD Therapeutics LLC.

What is Neovascularx, Inc.'s most recent federal award?

Neovascularx, Inc.'s most recent federal grant award is Topical ophthalmic treatment for neovascular age-related macular degeneration (namd) - project summary the long-term… (R43EY038159), from National Eye Institute, on September 30, 2025.

On GovTribe

See Neovascularx, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors